Skip to main content

Table 3 Characteristics of selected E. cloacae isolates

From: Dynamics of colistin and tobramycin resistance among Enterobacter cloacae during prolonged use of selective decontamination of the digestive tract

Cluster Number of isolates Location of patients located in hospital 1 or 2 at time of culture Period of detection Resistance (n/n tested)
Colistin Tobramycin ESBL
A 49 Intensive care unit (34 patients ICU 1; 5 patients ICU 2) June 2009 – May 2014 non-S (46/47) non-S (46/47) positive (41/45)
B 38 Intensive care unit (29 patients ICU 1; 5 patients ICU 2) December 2009 – August 2014 non-S (37/38) non-S (38/38) positive (31/33)
C 3 Ward (2 patients hospital 1; 1 patient hospital 2) June 2013 – February 2014 S (3/3) S (3/3) negative (2/3)
D 5 Intensive care unit (3 patients ICU 1) September 2009 – May 2012 S (4/4) S (4/4) positive (4/4)
E 3 Ward (1 patient hospital 1) January 2014 – January 2014 S (1/1) S (1/1) positive (1/1)
F 2 Ward/outpatient (2 patients hospital 1) July 2013 – August 2014 S (2/2) S (2/2) negative (2/2)
G 2 Ward (1 patient hospital 1) February 2012 – April 2012 S (2/2) S (2/2) positive (1/2)
H 19 Intensive care unit (6 patients hospital 1), ward (5 patients hospital 1) April 2010 – July 2014 S (13/14) non-S (13/14) positive (7/14)
  1. ESBL extended-spectrum beta-lactamase, ICU intensive care unit, n number, non-S non-susceptible, S susceptible